Blood Bank Reagents
This notice announces the intent by the Regional Health Contracting Office -
Pacific in support of Tripler Army Medical Center to procure Item# 71952 - Resolve Panel B; Item# 721380 - Anti-JKA BioClone; Item# 721480 - Anti-JKB BioClone; Item# 715280 - Anti-Lea; Item# 715380 - Anti-Leb, Item# 717380 Anti-D, and Item# Z488 FetalScreen, for the Department of Microbiology at Tripler Army Medical Center.
Specifically the government intends to procure Blood Bank Reagents
manufactured by Ortho Clinical Diagnostics, 1001 US HWY Route 202,
Raritan NJ, 08869-1424.
Ortho Clinical Diagnostics is the only company to provide reagents that have already been validated by Tripler Army Blood Bank and the Department of Pathology. These reagents are traditional antisera and reagent red blood cells. Items used for blood manufacturing and distribution must gain approval from the FDA (CFRs 200-299 and parts 600-799), AABB, and MEDCOM DoD Army Blood Program prior to usage. Any deviation from these reagents/supplies once validation has occurred may prohibit Tripler Army Medical Center from operating under the license that is shared with two other Army Testing sites for collection, manufacturing, and releasing of a biological/pharmaceutical product.
The NAICS code is 325413.
This announcement fulfills the synopsis requirements under FAR 5.201 and 5.203. This Notice of Intent is not a request for competitive quotes. Information received in response to this notice will be considered solely for the purpose of determining whether a competitive procurement is in the best interest of the Government. If no written responses are received by 25 May 2018, the solicitation will be issued as only one source. All questions and responses concerning this notice shall be emailed to Mr. Riley Yogi at riley.r.yogi.civ@mail.mil.
Riley Yogi, Phone 8084385118, Email riley.r.yogi.civ@mail.mil
